Pediatric Clinical Trials

Pediatric Neuroblastoma

If you would like to inquire about all open trials, please contact 919.684.3401.

2 trials identified.

An Open Label, Expanded Access Protocol Using (131)I-Metaiodobenzylguanidine (I-MIBG) Therapy in Patients with Refractory Neuroblastoma
Phase: Other
Sponsor: OTHER
Principal Investigator: Michael Armstrong
Contact: Dr. Michael Armstrong
Phone: 919.684.3401
Reference Number: 00012332
View this trial at ClinicalTrials.gov

ANBL1221 A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# 683864, IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 764038, IND# 4308) in Children with Refractory, Relapsed or Progressive Neuroblastoma
Phase: Phase II
Sponsor: Cooperative Group Initiated
Principal Investigator: Susan Kreissman
Contact: Dr. Susan Kreissman
Phone: 919.684.3401
Reference Number: 00044246
View this trial at ClinicalTrials.gov